Redcare Pharmacy NV Stock

Equities

RDC

NL0012044747

Drug Retailers

Market Closed - Xetra 11:35:22 2024-04-18 am EDT 5-day change 1st Jan Change
134.8 EUR -1.03% Intraday chart for Redcare Pharmacy NV -1.89% +2.43%
Sales 2024 * 2.38B 2.54B Sales 2025 * 2.91B 3.1B Capitalization 2.72B 2.9B
Net income 2024 * -6M -6.39M Net income 2025 * 49M 52.15M EV / Sales 2024 * 1.21 x
Net Debt 2024 * 163M 173M Net Debt 2025 * 145M 154M EV / Sales 2025 * 0.99 x
P/E ratio 2024 *
-405 x
P/E ratio 2025 *
65.6 x
Employees 1,900
Yield 2024 *
-
Yield 2025 *
-
Free-Float 96.36%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.03%
1 week-1.89%
Current month-11.11%
1 month-4.30%
3 months+8.53%
6 months+18.87%
Current year+2.43%
More quotes
1 week
131.50
Extreme 131.5
139.50
1 month
131.50
Extreme 131.5
153.00
Current year
118.05
Extreme 118.05
153.00
1 year
81.64
Extreme 81.64
153.00
3 years
36.51
Extreme 36.51
195.70
5 years
28.30
Extreme 28.3
249.00
10 years
24.00
Extreme 24
249.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 23-07-31
Director of Finance/CFO 51 20-01-31
Chief Operating Officer - -
Members of the board TitleAgeSince
Chairman 52 15-12-31
Founder 60 00-12-31
Director/Board Member 53 22-04-13
More insiders
Date Price Change Volume
24-04-18 134.8 -1.03% 57,097
24-04-17 136.2 -1.02% 52,448
24-04-16 137.6 +1.18% 68,483
24-04-15 136 -1.95% 81,805
24-04-12 138.7 +0.95% 59,094

Delayed Quote Xetra, April 18, 2024 at 11:35 am EDT

More quotes
Shop Apotheke Europe NV is a company based in the Netherlands that retails pharmaceutical products online. The Company focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The Company is active in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
134.8 EUR
Average target price
153.5 EUR
Spread / Average Target
+13.84%
Consensus

Quarterly revenue - Rate of surprise